Research Scientist II Bristol-Myers Squibb Company New Brunswick
As we continue to face COVID-19 challenges head-on, the industry needs to find opportunities to leverage novel technology to continue developing and delivering medicines for our patients. With limited staff on-site, we employed augmented reality (AR) technology, combined with remote desktop capabilities to enable real-time NIR blend monitoring to reduce the risk to batch production for a development asset. This allowed us to ensure our development timeline and opened our eyes to new ways of leveraging technology. The AR headset worn by operators during manufacturing enabled hands-free video and audio in real-time between the operator and PAT SME. Adding the remote desktop application provided additional ability to configure and run the PAT tools remotely. Having the on-line NIR blend data enabled enhanced understanding of process dynamics and mixing characteristics that was unobtainable without these technologies. This paves a pathway for working with CROs and CMOs efficiently for tech-transfers without travelling.
Upon completion, participant will be able to learn about novel technologies to enable remote collaboration and real-time communication.
Upon completion, participant will be able to use Augmented Reality to improve process efficiency and enable real-time communication as needed to solve problems.
Upon completion, participant will be able to understand the concept of connecting to PCs remotely to enable the setup of PC software and applications to run software from a distance.